Shenzhen Pregene Biopharma Co., Ltd. (China)
首页 关于普瑞金 公司介绍 Company Profile 深圳普瑞金生物药业股份有限公司为国家高新技术企业、广东省细胞与基因治疗创新药物工程技术研究中心、深圳市专精特新企业，投资方股东包括国家中小企业发展基金、国科嘉和、海尔资本、深圳资本集团、华邦健康（002004）等。多年深耕于细胞与基因治疗药物领域，产品管线包括多个靶点的CAR-T、CAR-NK药物等，适应症涵盖血液系统肿瘤、实体瘤和自身免疫疾病等多个治疗领域。普瑞金坚持技术平台化、平台产品化、产品商业化、商业国际化的发展策略和道路，是目前业内率先实现CAR-T细胞药物全球多区域授权的领先创新细胞药物企业。经过多年投入和发展，普瑞金已经建立了完整的细胞药物研发和生产质量管理体系，成功搭建了纳米抗体筛选、免疫细胞药物发现、质粒/病毒载体工艺开发和生产、细胞工艺开发和生产的创新和产业化核心技术平台，通过了ISO9001质量管理体系认证。 公司各产品管线呈阶梯式发展，后备技术丰富，发展前景广阔。展望未来，公司将以为临床治疗开发急需的细胞与基因药物为己任，以核酸类、基因载体、细胞工程产业化技术平台为核心，进一步加强源头研发，申请和拥有一
Basic Information
- Category: business
- Website: https://www.pregene.com
Documented Facts
- Phone: 0755-85204032 (No linked source recorded for this statement.)
- Email: pregene@pregene.com (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Shenzhen Pregene Biopharma Co., Ltd. (China).
- Canonical profile: https://brandsource.ai/brands/shenzhen-pregene-biopharma-co-ltd-china
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/shenzhen-pregene-biopharma-co-ltd-china/json-ld
- Citation profile API: https://brandsource.ai/api/brands/shenzhen-pregene-biopharma-co-ltd-china/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (62/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Shenzhen Pregene Biopharma Co., Ltd. (China) is listed in business on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.